Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02729922 · ClinicalTrials.gov registry record
Registry of Patients With CardioMEMS
A clinical trial of Heart Failure, Congestive, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT02729922: Completed study of Heart Failure, Congestive, sponsored by University of Pennsylvania.
NCT02729922 is a study of Heart Failure, Congestive that has completed, run by University of Pennsylvania. The registered enrollment target is 30 participants, below the 674-participant average among 39 other Heart Failure, Congestive trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02729922, a study of Heart Failure, Congestive, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
CardioMEMS is an implantable wireless hemodynamic monitoring system which can transmit the pulmonary artery pressure. This device is FDA approved to be used as a diagnostic tool to help management of selected heart failure patients. Heart failure patients with NYHA class III heart failure, irrespective of the left ventricular ejection fraction, and a previous hospital admission for heart failure in the past 12 months, without stage IV or V chronic kidney disease are candidates to receive a CardioMEMS device. Our goal is to create a registry of all patients that receive a CardioMEMS device and monitor outcomes, primarily heart failure hospitalizations, heart failure related quality of life and re-admissions.
Primary Outcome
Number of admissions to the hospital for the treatment of heart failure
Conditions Studied
Interventions
- DEVICE Cardiomems
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2016-03 |
| Est. Completion | 2025-06 |
What the finished NCT02729922 record still lists
NCT02729922 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 674-participant average among 39 other Heart Failure, Congestive trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Heart Failure, Congestive appearing as the primary indexed condition, and to 1 intervention - of which Cardiomems is the first listed.
NCT02729922 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02729922 about?
NCT02729922 is a clinical study titled "Registry of Patients With CardioMEMS". CardioMEMS is an implantable wireless hemodynamic monitoring system which can transmit the pulmonary artery pressure. This device is FDA approved to be used as a diagnostic tool to help management of selected heart failure patients. Heart failure patients with NYHA class III heart failure, irrespect...
What is the current status of trial NCT02729922?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2016-03. Estimated completion is 2025-06.
What conditions does trial NCT02729922 study?
This clinical trial studies the following conditions: Heart Failure, Congestive.
What interventions are being tested in trial NCT02729922?
The interventions under investigation include: Cardiomems (DEVICE).
Who is sponsoring clinical trial NCT02729922?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02729922 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure, Congestive
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02729922's enrollment target sits among peer trials
30 33rd of 39 higher than 6 of 39 other Heart Failure, Congestive trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure, Congestive trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention
RECRUITING
-
Magnetic Resonance Spectroscopy Studies of Cardiac Muscle Metabolism
RECRUITING
-
Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts
RECRUITING · Phase 4
-
The ROle of Compression StocKings in Heart Failure Patients
RECRUITING · NA
-
Comparison of Noninvasive vs. Invasive Hemodynamic Measurements
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia